Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 370825, 7 pages
http://dx.doi.org/10.1155/2014/370825
Research Article

Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients

1Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China
2Jilin Provincial Key Laboratory of Molecular Epidemiology, School of Public Health, Jilin University, Changchun 130021, China
3Jilin Provincial Key Laboratory of Surgical Translational Medicine, Department of Thyroid and Parathyroid Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China

Received 5 August 2014; Accepted 30 September 2014; Published 16 October 2014

Academic Editor: Małgorzata Kotula-Balak

Copyright © 2014 Yulu Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Xing, A. S. Alzahrani, K. A. Carson et al., “Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer,” The Journal of the American Medical Association, vol. 309, no. 14, pp. 1493–1501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Y. Choi, B. H. Hwang, K. C. Jung et al., “Clinical significance of microscopic anaplastic focus in papillary thyroid carcinoma,” Surgery, vol. 154, no. 1, pp. 106–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Cipollini, S. Pastor, F. Gemignani et al., “TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations,” International Journal of Cancer, vol. 133, no. 12, pp. 2843–2851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. Brenner, G. Neta, E. M. Sturgis et al., “Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer,” PLoS ONE, vol. 8, no. 3, Article ID e57243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Sturgis and G. Li, “Molecular epidemiology of papillary thyroid cancer: in search of common genetic associations,” Thyroid, vol. 19, no. 10, pp. 1031–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Xu, G. Li, Q. Wei, A. K. El-Naggar, and E. M. Sturgis, “Family history of cancer and risk of sporadic differentiated thyroid carcinoma,” Cancer, vol. 118, no. 5, pp. 1228–1235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Rahbari, L. Zhang, and E. Kebebew, “Thyroid cancer gender disparity,” Future Oncology, vol. 6, no. 11, pp. 1771–1779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Ron, J. H. Lubin, R. E. Shore et al., “Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies,” Radiation Research, vol. 141, no. 3, pp. 259–277, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sinnott, E. Ron, and A. B. Schneider, “Exposing the thyroid to radiation: a review of its current extent, risks, and implications,” Endocrine Reviews, vol. 31, no. 5, pp. 756–773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Enewold, K. Zhu, E. Ron et al., “Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005,” Cancer Epidemiology Biomarkers & Prevention, vol. 18, no. 3, pp. 784–791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. W. Jung, S. Park, H. J. Konget et al., “Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008,” Cancer Research and Treatment, vol. 43, no. 1, pp. 1–11, 2011. View at Publisher · View at Google Scholar
  12. J. A. Sipos and E. L. Mazzaferri, “Thyroid cancer epidemiology and prognostic variables,” Clinical Oncology, vol. 22, no. 6, pp. 395–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Hundahl, I. D. Fleming, A. M. Fremgen, and H. R. Menck, “A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995,” Cancer, vol. 83, no. 12, pp. 2638–2648, 1998. View at Google Scholar
  14. R. M. Tuttle, D. W. Ball, D. Byrdet et al., “Thyroid carcinoma,” Journal of the National Comprehensive Cancer Network, vol. 8, no. 11, pp. 1228–1274, 2010. View at Google Scholar
  15. I. Landa, S. Ruiz-Llorente, C. Montero-Conde et al., “The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors,” PLoS Genetics, vol. 5, no. 9, Article ID e1000637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Xing, “BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications,” Endocrine Reviews, vol. 28, no. 7, pp. 742–762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Basolo, R. Giannini, P. Faviana et al., “Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene,” Journal of Endocrinology, vol. 182, no. 3, pp. 479–484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Gudmundsson, P. Sulem, D. F. Gudbjartsson et al., “Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations,” Nature Genetics, vol. 41, no. 4, pp. 460–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Ricaud, C. Proux, J.-P. Renou et al., “ATM-mediated transcriptional and developmental responses to γ-rays in Arabidopsis,” PLoS ONE, vol. 2, no. 5, article e430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Savitsky, A. Bar-Shira, S. Gilad et al., “A single ataxia telangiectasia gene with a product similar to PI-3 kinase,” Science, vol. 268, no. 5218, pp. 1749–1753, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. M. F. Lavin, S. Scott, N. Gueven, S. Kozlov, C. Peng, and P. Chen, “Functional consequences of sequence alterations in the ATM gene,” DNA Repair, vol. 3, no. 8-9, pp. 1197–1205, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. C. J. Bakkenist and M. B. Kastan, “DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation,” Nature, vol. 421, no. 6922, pp. 499–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Xu, E. C. Morari, Q. Wei, E. M. Sturgis, and L. S. Ward, “Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 6, pp. 1913–1921, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. F. Lavin, “Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer (Nature Reviews Molecular Cell Biology, vol. 9, pp. 759–769, 2008),” Nature Reviews Molecular Cell Biology, vol. 9, no. 12, p. 927, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Flanagan, M. Munoz-Alegre, S. Henderson et al., “Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients,” Human Molecular Genetics, vol. 18, no. 7, pp. 1332–1342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Kim, H. Kim, K. Y. Lee et al., “Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk,” Human Molecular Genetics, vol. 15, no. 7, pp. 1181–1186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. N. M. Akulevich, V. A. Saenko, T. I. Rogounovitch et al., “Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma,” Endocrine-Related Cancer, vol. 16, no. 2, pp. 491–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Meyer, B. Wilhelm, T. Dörk et al., “ATM missense variant P1054R predisposes to prostate cancer,” Radiotherapy and Oncology, vol. 83, no. 3, pp. 283–288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. F. Rudd, G. S. Sellick, E. L. Webb, D. Catovsky, and R. S. Houlston, “Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia,” Blood, vol. 108, no. 2, pp. 638–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. He, Q. Chen, and B. Li, “ATM in oral carcinogenesis: association with clinicopathological features,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 9, pp. 1013–1020, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Kang, R.-F. Guo, X.-H. Tan, M. Zhao, Z.-B. Tang, and Y.-Y. Lu, “Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 638, no. 1-2, pp. 17–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Sun, X. Guo, X. Qian et al., “Activation of the ATM-snail pathway promotes breast cancer metastasis,” Journal of Molecular Cell Biology, vol. 4, no. 5, pp. 304–315, 2012. View at Publisher · View at Google Scholar
  33. J. Lee, C. O. Sung, E. J. Lee et al., “Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the atm gene,” PLoS ONE, vol. 7, no. 4, Article ID e34456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. B. H.-H. Lang, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, and K.-Y. Wan, “Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 730–738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. E. L. Mazzaferri and R. T. Kloos, “Current approaches to primary therapy for papillary and follicular thyroid cancer,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 4, pp. 1447–1463, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Solé, E. Guinó, J. Valls, R. Iniesta, and V. Moreno, “SNPStats: a web tool for the analysis of association studies,” Bioinformatics, vol. 22, no. 15, pp. 1928–1929, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Gu, Y. Yu, L. Ai et al., “Association of the ATM gene polymorphisms with papillary thyroid cancer,” Endocrine, vol. 45, no. 3, pp. 454–461, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Sun, Y. Gao, W. Tan et al., “A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers,” Nature Genetics, vol. 39, no. 5, pp. 605–613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Chen, B. Dong, Z. Lu et al., “A functional single nucleotide polymorphism in promoter of ATM is associated with longevity,” Mechanisms of Ageing and Development, vol. 131, no. 10, pp. 636–640, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Dong, Z. Hu, Y. Shu et al., “Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis,” Molecular Carcinogenesis, vol. 51, no. 7, pp. 546–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. H.-C. Wang, W.-S. Chang, R. U.-Y. Tsai et al., “Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in taiwanese females,” Anticancer Research, vol. 30, no. 12, pp. 5217–5222, 2010. View at Google Scholar · View at Scopus
  43. H.-M. Wang, Y.-S. Shi, Q.-S. Li, Y. Liu, and X.-K. Zheng, “Association between single nucleotide polymorphism locus rs189037 in the promoter of ATM gene and nasopharyngeal carcinoma susceptibility in Cantonese,” Journal of Southern Medical University, vol. 31, no. 11, pp. 1863–1866, 2011. View at Google Scholar · View at Scopus
  44. B. A. Kilfoy, S. S. Devesa, M. H. Ward et al., “Gender is an age-specific effect modifier for papillary cancers of the thyroid gland,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 4, pp. 1092–1100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Vivacqua, D. Bonofiglio, L. Albanito et al., “17β-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30,” Molecular Pharmacology, vol. 70, no. 4, pp. 1414–1423, 2006. View at Publisher · View at Google Scholar · View at Scopus